The board of directors Clearbridge Health Limited advised that, following a preliminary review of the Group's unaudited financial results for the financial year ended 31 December 2021 and based on information currently available to the Board, the Group is likely to report a net loss for fiscal year 2021 as compared to a net profit of approximately SGD 2.07 million for the financial year ended 31 December 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 SGD | -9.09% | -9.09% | -37.50% |
29/04 | Clearbridge Health Awards Shares Under Performance Share Plan | MT |
29/02 | Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-37.50% | 4.6M | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- 1H3 Stock
- News Clearbridge Health Limited
- Clearbridge Health Limited Provides Earnings Guidance for the Financial Year Ended 31 December 2021